Asymptomatic paroxysmal atrial fibrillation during intravenous magnesium sulfate treatment in preeclampsia

Moshe Oettinger, Yuri Perlitz

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Magnesium sulfate is commonly used as the anticonvulsant drug of choice for preeclampsia and eclampsia. It is effective, nontoxic to both mother and fetus, and side effects are rare within the therapeutic range. This report describes paroxysmal atrial fibrillation occurring at low serum levels of the drug during the treatment of preeclampsia.

Original languageEnglish
Pages (from-to)244-246
Number of pages3
JournalGynecologic and Obstetric Investigation
Volume36
Issue number4
DOIs
StatePublished - 1993
Externally publishedYes

Keywords

  • Cardiotoxicity
  • Magnesium sulfate
  • Preeclampsia

Fingerprint

Dive into the research topics of 'Asymptomatic paroxysmal atrial fibrillation during intravenous magnesium sulfate treatment in preeclampsia'. Together they form a unique fingerprint.

Cite this